Alumis Inc.(ALMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ALMS Alumis Inc.

Market Closed 06-18 16:00:00 EDT

23.41

+0.36

+1.56%

盘后23.87

+0.46+1.96%

19:59 EDT

High24.21	Low22.81	Vol1.88M
Open23.80	D1 Closing23.05	Amplitude6.05%
Mkt Cap2.98B	Tradable Cap1.79B	Total Shares127.20M
T/O43.97M	T/O Rate2.46%	Tradable Shares76.48M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ALMS","market":"US","secType":"STK","nameCN":"Alumis Inc.","latestPrice":23.41,"timestamp":1781812800000,"preClose":23.05,"halted":0,"volume":1883737,"hourTrading":{"tag":"盘后","latestPrice":23.87,"preClose":23.41,"latestTime":"19:59 EDT","volume":108853,"amount":2547367.8657,"timestamp":1781827164104,"change":0.46,"changeRate":0.01965,"amplitude":0.01965},"delay":0,"changeRate":0.015618221258134465,"floatShares":76484700,"shares":127199333,"eps":-1.8621956,"marketStatus":"Market Closed","change":0.36,"latestTime":"06-18 16:00:00 EDT","open":23.8,"high":24.205,"low":22.81,"amount":43973862.34115,"amplitude":0.060521,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.8621956,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1782115200000},"marketStatusCode":7,"adr":0,"listingDate":1719547200000,"exchange":"NASDAQ","adjPreClose":23.05,"preHourTrading":{"tag":"盘前","latestPrice":23.81,"preClose":23.05,"latestTime":"09:29 EDT","volume":2703,"amount":63929.615268,"timestamp":1781789399999,"change":0.76,"changeRate":0.032972,"amplitude":0.037744},"postHourTrading":{"tag":"盘后","latestPrice":23.87,"preClose":23.41,"latestTime":"19:59 EDT","volume":108853,"amount":2547367.8657,"timestamp":1781827164104,"change":0.46,"changeRate":0.01965,"amplitude":0.01965},"volumeRatio":1.2040424915656192,"impliedVol":0.6743,"impliedVolPercentile":0.0996},"requestUrl":"/m/hq/s/ALMS/tweets","defaultTab":"tweets","newsList":[{"id":"2643294634","title":"Alumis rises 10.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643294634","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643294634?lang=en_us&edition=fundamental","pubTime":"2026-06-13 00:09","pubTimestamp":1781280582,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) is up 10.3%, or $2.16 to $23.06. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-rises-10-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-rises-10-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636397859","title":"Alumis Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2636397859","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636397859?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:36","pubTimestamp":1779194160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 19, 2026 08:36 ET (12:36 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636855164","title":"Chardan Raises Price Target on Alumis to $40 From $38, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2636855164","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636855164?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:59","pubTimestamp":1779191954,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) has an average rating of buy and mean price target of $39.90, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636500961","title":"Alumis announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2636500961","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636500961?lang=en_us&edition=fundamental","pubTime":"2026-05-19 04:28","pubTimestamp":1779136100,"startTime":"0","endTime":"0","summary":"Alumis will hold its 2026 annual stockholders meeting online on June 30, 2026.Shareholders will vote on electing three Class II directors to terms running through the 2029 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL34MX0Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636064216","title":"Should Alumis’ (ALMS) Envudeucitinib-Centric Strategy After Q1 Losses Require Action From Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2636064216","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636064216?lang=en_us&edition=fundamental","pubTime":"2026-05-17 03:21","pubTimestamp":1778959312,"startTime":"0","endTime":"0","summary":"Alumis Inc. has reported first-quarter 2026 results alongside past Phase 3 data showing strong efficacy for its oral TYK2 inhibitor envudeucitinib in moderate-to-severe plaque psoriasis, while revenue declined to US$1.74 million and net loss reached US$93.05 million.\nA key insight is that Alumis is pairing these psoriasis results with plans for a New Drug Application in late 2026 and potentially pivotal systemic lupus erythematosus data in the third quarter of 2026, positioning...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alms/alumis/news/should-alumis-alms-envudeucitinib-centric-strategy-after-q1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alms/alumis/news/should-alumis-alms-envudeucitinib-centric-strategy-after-q1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","ALMS","BK4211","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635485087","title":"Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday Amid Oil Surge, Higher Yields, Geopolitical Uncertainty","url":"https://stock-news.laohu8.com/highlight/detail?id=2635485087","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635485087?lang=en_us&edition=fundamental","pubTime":"2026-05-15 21:14","pubTimestamp":1778850854,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.9% and the actively traded Invesco QQQ Trust (QQQ) was 1.3% lower in Friday's premarket activity as mounting inflation con","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["USO","XLV","VDC","QQQ","BITO","RTH.AU","RTH","VIS","XSD","SLV","BETH","BP","SPY.AU","IWM","VHT.AU","IYW","XLP","VHT","IYH","BW","GLD","IBB","EQR",".IXIC","FAS","IGM","IYK","TSM","ALMS","XLF","XLK","XLY",".DJI","XRT","IGV","XLI","SOXX","EETH","XLE","FDN","BPOP","IYE","FAZ","EEM","IVV","UNG","IYJ","TSLA","SPY","HSBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635087470","title":"Alumis Is Maintained at Overweight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2635087470","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635087470?lang=en_us&edition=fundamental","pubTime":"2026-05-15 21:14","pubTimestamp":1778850840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 15, 2026 09:14 ET (13:14 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGF","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635531087","title":"Alumis price target raised to $39 from $38 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2635531087","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635531087?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:49","pubTimestamp":1778849344,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Terence Flynn raised the firm’s price target on Alumis (ALMS) to $39 from $38 and keeps an Overweight rating on the shares. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-price-target-raised-to-39-from-38-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-price-target-raised-to-39-from-38-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635089099","title":"Alumis Q1 Loss Narrows, Revenue Falls; Shares Down Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2635089099","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635089099?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:44","pubTimestamp":1778845450,"startTime":"0","endTime":"0","summary":"Alumis  reported a Q1 net loss late Thursday of $93.1 million, narrowing from a loss of $99 million a year earlier.Analysts polled by FactSet expected a loss of $93.6 million.Revenue for the quarter ended March 31 was $1.7 million, down from $17.4 million a year earlier.Analysts surveyed by FactSet expected $2.1 million.The company had cash, cash equivalents and marketable securities of $569.5 million as of March 31.Alumis continues to expect its existing cash, cash equivalents and marketable securities to fund operating expenses and capital expenditure requirements into Q4 2027, it said.The company's shares were down 2% in premarket activity Friday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635471086","title":"HC Wainwright Downgrades Alumis to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2635471086","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635471086?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:13","pubTimestamp":1778843623,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) has an average rating of buy and mean price target of $39.90, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635300086","title":"Alumis price target raised to $34 from $32 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2635300086","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635300086?lang=en_us&edition=fundamental","pubTime":"2026-05-15 18:58","pubTimestamp":1778842727,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Yatin Suneja raised the firm’s price target on Alumis (ALMS) to $34 from $32 and keeps a Buy rating on the shares. The firm’s ra...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alumis-price-target-raised-to-34-from-32-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alumis-price-target-raised-to-34-from-32-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635085496","title":"Alumis Cut to Neutral From Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2635085496","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635085496?lang=en_us&edition=fundamental","pubTime":"2026-05-15 18:52","pubTimestamp":1778842320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 15, 2026 06:52 ET (10:52 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635088868","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2635088868","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635088868?lang=en_us&edition=fundamental","pubTime":"2026-05-15 18:00","pubTimestamp":1778839200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.,·H World ADR                                     1Q       .45       BMO. ,·RBC Bearings                                     4Q      3.33   8:00 AM. ,·Compugen Ltd.                                   1Q      (.07)  7:00 AM. ,·iQIYI ADR                                         1Q      (.03)  5:00 AM. ,·Modiv Ind Cl C                                   1Q       .01. ,·8x8 Inc.                                        4Q       .08   4:05 PM. ,·Amer Sports                                       1Q       .31   6:00 AM. ,·Bilibili Spon                                   1Q       .17   6:00 AM. ,·Canaan Spon ADR                                  1Q      (.03)      BMO. ,·CAVA Grp                                        1Q       .17   4:10 PM. ,·Ceragon Net                                     1Q       .01   7:00 AM. ,·Eagle Materials                     ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EGHT","GDS","IMVT","IQ","CRNT","BULL","CPRT","DE","EXP","GCTS","HSAI","ECC","CGEN","BZ","BORR","EDRY","BIDU","ADI","BEKE","BLTE","ALMS","EARN","ENS","BILI","INTU","HTHT","CDLR","CAN","ELF","HAS","CAVA","DECK","AGYS","FLO","GCO","BURL","FATN","BNTC","HD","AS","AAP","DAVA","BTM","CRVO","DOMO","CMBT","CAE","GLNG","BBW","HLNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635088619","title":"Alumis Inc. (ALMS) Gets a Buy from Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2635088619","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635088619?lang=en_us&edition=fundamental","pubTime":"2026-05-15 17:47","pubTimestamp":1778838477,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Derek Archila reiterated a Buy rating on Alumis Inc. yesterday and set a price target of $51.00. The company’s shares closed ye...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alumis-inc-alms-gets-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alumis-inc-alms-gets-a-buy-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4559","LU0742534661.SGD","LU0310799852.SGD","LU1363072403.SGD","PGF","LU0208291251.USD","BK4501","LU0211327993.USD","LU0417517546.SGD","LU0251131958.USD","LU0320765489.SGD","BK4582","IE00B19Z3581.USD","LU1069347547.HKD","LU0128525689.USD","LU0149725797.USD","BK4207","LU1267930227.SGD","LU1506573853.SGD","LU2236285917.USD","LU2361044949.HKD","BK4585","LU0971096721.USD","IE00B7SZLL34.SGD","LU1814569148.SGD","LU1267930573.SGD","ALMS","LU0154236417.USD","LU0052756011.USD","LU2461242641.AUD","LU0942090050.USD","LU1035773651.USD","LU0256863811.USD","LU0314106906.USD","LU0310800379.SGD","LU0106831901.USD","LU1267930490.SGD","IE0002270589.USD","LU0683600562.USD","LU0251142724.SGD","LU0868494708.USD","LU1074936037.SGD","LU1668664300.SGD","LU0787776722.HKD","LU1280957306.USD","BK4588","LU0708994859.HKD","LU1894683264.USD","LU0267386448.USD","LU0640476718.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635721498","title":"Alumis Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635721498","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635721498?lang=en_us&edition=fundamental","pubTime":"2026-05-15 05:46","pubTimestamp":1778795178,"startTime":"0","endTime":"0","summary":"Alumis Inc reports results for the quarter ended December 31 - Earnings SummaryAlumis Inc ALMS.OQ reported a quarterly adjusted loss of 74 cents per share for the quarter ended December 31, higher tha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL8N41R2MV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635172608","title":"Alumis Q1 EPS $(0.74) Beats $(0.77) Estimate, Sales $1.741M Miss $2.767M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635172608","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635172608?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:51","pubTimestamp":1778791891,"startTime":"0","endTime":"0","summary":"Alumis (NASDAQ:ALMS) reported quarterly losses of $(0.74) per share which beat the analyst consensus estimate of $(0.77) by 3.9 percent. This is a 59.34 percent increase over losses of $(1.82) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52583131/alumis-q1-eps-0-74-beats-0-77-estimate-sales-1-741m-miss-2-767m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Alumis Q1 EPS $(0.74) Beats $(0.77) Estimate, Sales $1.741M Miss $2.767M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635725799","title":"Alumis Q1 revenue drops, net loss narrows after trial completion","url":"https://stock-news.laohu8.com/highlight/detail?id=2635725799","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635725799?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:30","pubTimestamp":1778790646,"startTime":"0","endTime":"0","summary":"Alumis Q1 revenue drops, net loss narrows after trial completionOverviewUS biopharma firm's Q1 revenue fell sharply from prior year due to lower license revenueQ1 net loss narrowed as R&D and admin ex","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL1N41R1AH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635140725","title":"Alumis Q1 FY26 net loss narrows 6% to $93.05 million; revenue drops 90% to $1.74 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635140725","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635140725?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:23","pubTimestamp":1778790190,"startTime":"0","endTime":"0","summary":"Alumis posted Q1 net loss of USD 93.05 million, narrowing 6% from year-ago period.Revenue fell 90% to USD 1.74 million, as license revenue dropped to no revenue from USD 17.39 million a year earlier.Operating loss improved 3% to USD 98.41 million, while total operating expenses declined 16% to USD 100.15 million.Research and development expense decreased 16% to USD 81.54 million on lower CRO, CMO and clinical trial spending, partly offset by higher personnel-related costs.Company ended March 31, 2026 with cash, cash equivalents and marketable securities of USD 569.5 million, planning to submit an NDA for envu in psoriasis in second half of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content u","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL9dyn3m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635231857","title":"Alumis posts corporate deck on next-generation TYK2 inhibitors for immune-mediated diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2635231857","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635231857?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:07","pubTimestamp":1778789225,"startTime":"0","endTime":"0","summary":"Alumis highlighted Phase 3 plaque psoriasis data for oral TYK2 inhibitor envudeucitinib, citing Week 24 PASI 100 rates of 41.0% in ONWARD1 and 39.5% in ONWARD2.Week 24 sPGA-0 rates were 41.6% in ONWARD1 and 40.6% in ONWARD2, with PASI 90 responses emerging by Week 4.2026 milestones include additional psoriasis data presentations, an NDA filing for envudeucitinib in plaque psoriasis, topline Phase 2b data in systemic lupus erythematosus.Portfolio update flagged A-005 for neuroinflammation, with strategy focused on expanding TYK2 indications.Market outlook cited psoriasis opportunity of about $40 billion by 2030, lupus about $11 billion, broader TYK2-addressable market projected above $180 billion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL5fWsNW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635688723","title":"BRIEF-Alumis  Q1 Operating Expenses USD 100.15 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635688723","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635688723?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:05","pubTimestamp":1778789152,"startTime":"0","endTime":"0","summary":"BRIEF-Alumis Q1 Operating Expenses USD 100.15 Million\n\n\nMay 14 (Reuters) - Alumis Q1 income from operations USD -98.409 million.\n\nQ1 net income USD -93.053 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nPLX5AF69B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alumis.com","stockEarnings":[{"period":"1week","weight":0.1201},{"period":"1month","weight":0.0876},{"period":"3month","weight":-0.0658},{"period":"6month","weight":1.0735},{"period":"1year","weight":6.7774},{"period":"ytd","weight":1.3986}],"compareEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.1514},{"period":"6month","weight":0.0972},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.0951}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Alumis Inc.","nameEN":"Alumis Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alumis Inc.(ALMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Alumis Inc.(ALMS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Alumis Inc.,ALMS,Alumis Inc.股票,Alumis Inc.股票老虎,Alumis Inc.股票老虎国际,Alumis Inc.行情,Alumis Inc.股票行情,Alumis Inc.股价,Alumis Inc.股市,Alumis Inc.股票价格,Alumis Inc.股票交易,Alumis Inc.股票购买,Alumis Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alumis Inc.(ALMS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Alumis Inc.(ALMS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}